AtheroMed: Volcano to buy Menlo Park-based AtheroMed for $115M

AtheroMed, which has developed an FDA-approved catheter to treat arterial disease, has agreed to be acquired by Volcano Corp. for $115 million. The Menlo Park company led by CEO Mike MacKinnon had raised at least $37.7 million from investors since it was founded in 2006. Its investors include US Venture Partners, Canaan Partners, The Vertical Group and Kaiser Permanente Ventures. Volcano said that in addition to paying $115 million in cash at closing, which is expected to occur in the current quarter,…